Drug profile · INN
meprobamate
MEPROBAMATE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
meprobamate (MEPROBAMATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12390419
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 12384743
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
granted -
US 11998639
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 11560354
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
granted -
US 11439597
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10829443
Solvate form of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10512609
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10233174
Thiocarbamate prodrugs of tofacitinib
granted
Frequently asked questions
What is meprobamate?
meprobamate (MEPROBAMATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for meprobamate?
MEPROBAMATE is a marketed brand name for meprobamate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of meprobamate?
meprobamate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.